Back to search

Article

Rho2-dependent cell wall remodeling boosts the fungistatic activity of manogepix against <i>Aspergillus fumigatus</i>

2025-10-20

Abstract excerpt

<h4>ABSTRACT</h4> Fosmanogepix is a new antifungal agent currently undergoing phase 3 clinical trials. Its active moiety, manogepix, inhibits Gwt1 which is an enzyme essential for the assembly and attachment of glycosylphosphatidylinositol anchors to cell wall proteins. Manogepix has a strong fungistatic activity against most human pathogenic fungal species. Here we characterized the activity of manogepix against...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
89e3fd87-8f5d-5af9-ba36-7e0257d75f1a
DOI
10.1101/2025.10.20.683572
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Rho2-dependent cell wall remodeling boosts the fungistatic activity of manogepix against <i>Aspergillus fumigatus</i>DOI 10.1101/2025.10.20.683572
Select a neighboring publication to make it the new centre.